A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system ...

Merck will present data at the American Academy of Ophthalmology Annual Meeting next month. (Angus Liu/Fierce Pharma) Merck & Co.’s Brunello trial has hit its primary endpoint, shedding light on the ...

Merck stock sits near analyst targets that fall short of $200, yet a compressed fall calendar of FDA decisions and a pivotal cancer vaccine readout could force Wall Street to rethink the entire ...

Merck MRK.N and Moderna MRNA.O said on Wednesday a study of a personalized mRNA vaccine combined with the immunotherapy drug Keytruda reduced melanoma skin cancer recurrence and spread compared with ...

A personalized messenger RNA cancer treatment developed by Moderna and Merck enabled melanoma patients to live longer without signs of their disease coming back, results the companies say mark the ...

Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients ...

Merck beat second-quarter estimates and hiked its revenue outlook, as a slate of new products showed strong growth. But the pharmaceutical giant cut its profit guidance due to a charge tied to its ...

Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s nod, bolstering the drugmaker’s efforts to diversify beyond its ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade ...

Merck's deal with Protillion Biosciences follows a flurry of recent deals that included an enterprise partnership with Google AI. (Darren Incorvaia) AI drug design specialist Protillion Biosciences ...

Merck & Co. says it will settle a spate of lawsuits that blame the drugmaker’s blockbuster Gardasil cancer vaccine for causing autoimmune ailments that affect young women’s hearts and reproductive ...

The trial, in Cook County Circuit Court in Illinois, comes as Merck faces more than 600 similar cases over cosmetic talcum powder products that it purchased in 2009 but sold in 2014. Sidley Austin ...